SCHEMBL4774140

SCHEMBL4774140

CCn1c(-c2ccc(Cl)cc2)nc2c(=O)[nH]c(Cc3cccc(C(F)(F)F)c3)nc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
AVPR2 P30518 2/20 0.45
AVPR1A P37288 2/20 0.45
TP53 P04637 1/20 0.42
TPH1 P17752 1/20 0.41
TPH2 Q8IWU9 1/20 0.41
ADORA2B P29275 4/20 0.41
ADORA2A P29274 3/20 0.41
ADORA1 P30542 3/20 0.41
CDK2 P24941 4/20 0.40
CCNE2 O96020 3/20 0.40
CCNE1 P24864 3/20 0.40
P2RX3 P56373 1/20 0.40
PDE5A O76074 1/20 0.40
PDE9A O76083 1/20 0.40
PDE1A P54750 1/20 0.40
PDE1B Q01064 1/20 0.40
PDE1C Q14123 1/20 0.40
ADORA3 P0DMS8 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4776816 0.85 PIN1 (0.45) HTTL3MBTL1ADORA2BADORA2AADORA1
SCHEMBL4776112 0.84 HPGD (0.39) HTTCDK2CCNE2CCNE1PDE5A
SCHEMBL4768887 0.82 ALDH1A1 (0.40) HTTCDK2CCNE2CCNE1PDE5A
SCHEMBL4774324 0.82 ALDH1A1 (0.39) HTTCDK2CCNE2CCNE1PDE5A
SCHEMBL4767126 0.82 HPGD (0.39) HTTADORA2BADORA2ACDK2CCNE2
SCHEMBL4776924 0.81 HPGD (0.47) HTTTPH1TPH2CDK2CCNE2
SCHEMBL4776202 0.79 ALDH1A1 (0.39) HTTCDK2CCNE2CCNE1CCNB2
SCHEMBL4776139 0.78 ALDH1A1 (0.41) HTTAVPR2AVPR1ACDK2CCNE2
SCHEMBL4768853 0.77 ALDH1A1 (0.43) HTTAVPR2AVPR1ACDK2CCNE2
SCHEMBL4774287 0.76 ALDH1A1 (0.41) HTTCDK2CCNE2CCNE1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed